Marina Temkin

Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery.

Norwest Venture Partners, a 65-year-old firm backed solely by Wells Fargo, has raised its 17th fund at $3 billion. That's a noteworthy number, given that The sixty-five year old firm closed the same size fund as it did in 2021.

Asheem Chandna says he was so impressed with founder Bipul Sinha's grit and tech, he led Rubrik's $40 million Series B in 2015.

Iconiq Capital has raised $5.15 billion across two funds associated with the seventh growth fund family, according to SEC filings. The firm, which

When Itai Ben-Zaken's first startup failed in 2018, the former BCG consultant and Wharton MBA spent months trying to understand what he could have done

In 2017, Vinod Khosla told CNBC that the job "of the radiologist will be obsolete in five years." While the founder of Khosla Ventures later revised that

For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each

The fresh funds were raised from two investors who transferred the capital into a special purpose vehicle, a legal entity associated with the OpenAI Startup Fund.

photo of David Sacks reveals Glue, the AI company he’s been teasing on his All In podcast image VC and podcaster David Sacks has revealed a new AI chat app called Glue that fixes "Slack channel fatigue," he says. © 2024 TechCrunch. All rights reserved. For personal use only.

For years, Sammy Faycurry has been hearing from his dietician mom and sister about how poorly many Americans eat and their struggles with delivering nutritional counseling.